These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3172138)
1. Synthesis of fluorescent muramyl dipeptide congeners. 2. Hiebert CK; Kopp WC; Richerson HB; Barfknecht CF J Med Chem; 1988 Oct; 31(10):2022-4. PubMed ID: 3172138 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of a biologically active fluorescent muramyl dipeptide congener. Hiebert CK; Kopp WC; Richerson HB; Barfknecht CF J Med Chem; 1983 Dec; 26(12):1729-32. PubMed ID: 6644742 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, mass spectral characterization and immunoadjuvant activity of some novel lipophilic derivatives of muramyl dipeptides. Jain RK; Gupta CM; Saxena RK; Saxena RP; Saxena KC; Shukla R; Anand N; Costello CE Chem Phys Lipids; 1986; 41(3-4):237-64. PubMed ID: 3815623 [TBL] [Abstract][Full Text] [Related]
4. Antigenicity study of muroctasin. Yamaguchi F; Hattori H; Wagai N; Tsukada W Arzneimittelforschung; 1988 Jul; 38(7A):1034-7. PubMed ID: 3190797 [TBL] [Abstract][Full Text] [Related]
5. [Synthesis of lipophilic and fluorescent derivatives of N-acetylmuramoyl-L-alanyl-D-isoglutamine]. Bogomolov OV; Golovkina IV; Shvets VI; Bovin NV Bioorg Khim; 1993 Feb; 19(2):190-6. PubMed ID: 8498960 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin. Ogawa T; Kotani S; Shimauchi H Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372 [TBL] [Abstract][Full Text] [Related]
8. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2. Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716 [No Abstract] [Full Text] [Related]
9. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats. Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and immunological evaluation of the conjugates composed from a muramyl peptide GMDP and tuftsin. Titov VM; Meshcheryakova EA; Balashova TA; Andronova TM; Ivanov VT Int J Pept Protein Res; 1995 Apr; 45(4):348-55. PubMed ID: 7601608 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities. Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model. Saxena RP; Puri A; Saxena KC; Shukla R; Haq W; Rizvi SY; Kundu B; Mathur KB Indian J Exp Biol; 1991 Feb; 29(2):111-5. PubMed ID: 1869292 [TBL] [Abstract][Full Text] [Related]
13. A shortened synthesis of adjuvant dipeptide (MDP). Schwartzman SM; Ribi E Prep Biochem; 1980; 10(3):255-67. PubMed ID: 7413603 [TBL] [Abstract][Full Text] [Related]
14. Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs. Byars NE Infect Immun; 1984 May; 44(2):344-50. PubMed ID: 6609127 [TBL] [Abstract][Full Text] [Related]
15. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen. Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831 [TBL] [Abstract][Full Text] [Related]
16. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice. Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of conjugates between luteinizing hormone releasing hormone (LH-RH) and N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) models of totally synthetic vaccines. Bernard JM; Gras-Masse H; Drobecq H; Tartar A; Lefrancier P; Hosmalin A; Carelli C; Chedid L Int J Pept Protein Res; 1987 Apr; 29(4):455-63. PubMed ID: 3298096 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of (N-acetyl-1-O-acylmuramoyl)-L-alanyl-D-isoglutamines, and their immunoadjuvant activities. Hasegawa A; Hioki Y; Kiso M; Azuma I Carbohydr Res; 1983 Nov; 123(1):63-71. PubMed ID: 6667479 [TBL] [Abstract][Full Text] [Related]
19. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity of conjugates of adenosine with muramyl dipeptide and nor-muramyl dipeptide derivatives. Samsel M; Dzierzbicka K; Trzonkowski P Bioorg Med Chem Lett; 2014 Aug; 24(15):3587-91. PubMed ID: 24915876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]